Cyagen은 당사의 독점적인 TurboKnockout® 기술을 포함한 모든 배아줄기세포(Embryonic Stem Cell, ESC) 기반으로 한 gene targeting 서비스를 위한 BALB/c 마우스 모델의 가용성을 발표한 것을 자랑스럽게 생각한다.
Read More ›
2020년 3월 11일, 세계보건기구(WHO)에서는 신종 코로나바이러스 집단감염을 팬데믹(pandemic)으로 선언하였다. COVID-19를 예방하고 치료하기 위해서 우리는 이번 신종 코로나바이러스의 구조, 감염 및 면역 메커니즘에 대한 깊은 이해가 필요하다.
Read More ›
Since COVID-19 poses a significant threat to public health and also represents a challenge for antiviral drug development and administration globally, current efforts focus on prevention and control while accelerating the research on the SARS-CoV-2 coronavirus, which has caused the outbreak of COVID-19. So far, studies on the epidemiological and clinical characteristics of this illness is still growing, but there is significant anecdotal evidence of value.
Read More ›
At present, the prevention and treatment of coronavirus is the most urgent issue for scientific and medical research. In addition to the ACE2 host receptor target that is being highly focused on, what other targets deserve the attention of current coronavirus researchers? Herein, experts from Cyagen investigate the lesser-known targets that are pertinent to coronavirus research, aiming to provide some helpful references to guide scientific researchers.
Read More ›
At the end of 2019, a large-scale illness broke out from Wuhan, Hubei Province - a central province of China. The virus that cased this illness could enter the respiratory tract through droplets - moreover, the increasingly busy traffic conditions and travel around the holiday season made the virus spread extremely rapidly.
Read More ›
The recent emergence of Coronavirus Disease in 2019 (COVID-19), caused by infection by SARS-CoV-2, has put the world on high alert. People are concerned about how soon drugs and vaccines will be available after the isolation of virus strains and the completion of sequencing and comparative analysis.
Read More ›
We use cookies to ensure that we give you the best experience on our website. To learn about how we
keep your information safe, view our Privacy Policy.
OKPrivacy policy
